Medtech Insight is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Medicare Will Cover PET To Distinguish Alzheimer’s From Other Dementia

This article was originally published in The Gray Sheet

Executive Summary

CMS' decision to provide national coverage of FDG-PET imaging for some suspected dementia patients corresponds with the Neuroimaging Work Group of the Alzheimer's Association's consensus position
Advertisement

Related Content

CMS Could Use Higher Co-Pays To Control Technology Utilization – Tunis
CMS Could Use Higher Co-Pays To Control Technology Utilization – Tunis
CMS gives thumbs-up to PET/Alzheimer’s coverage
CMS gives thumbs-up to PET/Alzheimer’s coverage
CMS Coverage Of Post-Approval Studies Seeks To Improve Data For NCDs
CMS Coverage Of Post-Approval Studies Seeks To Improve Data For NCDs
Medicare PET/Alzheimer’s Disease Policy Criticized By Private Payor Group
PET Trial For Alzheimer’s Opens Door For CMS-Backed Research – Phurrough
Dx Firms Should Measure Patient Outcomes During Pivotal Trials – Consultant
Dx Firms Should Measure Patient Outcomes During Pivotal Trials – Consultant
Advertisement
UsernamePublicRestriction

Register

MT020436

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel